Private Market View

Rose Park Advisors

Venture capital · Boston, MA

AUM
$33.3M
Portfolio companies
9
Recorded deals
1
Last investment
Jul 2016

Key facts

  • Rose Park Advisors is a venture capital firm based in Boston, MA with 9 tracked portfolio companies.
  • Notable positions include Gusto, Nomi Health, RejuvenAir, Sirona, Reflexivity.
  • Private Market View records 1 deal participation by Rose Park Advisors.
  • Rose Park Advisors’s most recent recorded investment was in Jul 2016.
  • The team roster lists 1 person.
  • Rose Park Advisors reports $33.3M in regulatory assets under management across 7 private funds, per its SEC Form ADV (2026-04).

Registered with the SEC

Form ADV · 2026-04 · CRD 162017
Regulatory AUM
$33.3M
Private fund assets
$572.5M
Private funds
7 · 2 venture, 1 hedge, 4 other
Staff
13
Registered office
BOSTON, MA
SEC status
Approved

Reports custody of client assets.

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as ROSE PARK ADVISORS, LLC).

Free account
See the whole book
  • ·Every recorded deal — 1 rounds
  • ·Watchlist + alerts for Rose Park Advisors's activity
Create free account
No card required

Portfolio, priced

9 companies · by our current valuations
CompanyValuationRole
Gusto$9.3B
Nomi Health$1.7B
RejuvenAir$156.0M
Sirona$125.0M
Reflexivity$120.0M
Fetch Package$62.5M
Wholesail$57.6M
innRoad$11.8M
BioLite—

Recent deals

1 recorded
Jul 2016GustoSeries B2$90.0M
Team
1 people on record — 1 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked

What companies does Rose Park Advisors invest in?
Rose Park Advisors has 9 recorded portfolio companies, including Gusto, Nomi Health, RejuvenAir, Sirona.
What is Rose Park Advisors's AUM?
Rose Park Advisors manages approximately $33.3M in assets.
Is Rose Park Advisors actively investing?
Rose Park Advisors's most recent recorded investment was in Jul 2016.